2_SAGE_Appendicies_Background_final

More documents

Recommendations

Info

Tanzania no no responseBrazil yes Rapid monitoring of vaccination providedinformation to explain the reasons for nonvaccinationor for abandoning the recommendedvaccination schedule.Chile yes Conducted a small study, requested by theMINISTRY of Finance in 2012, study focused onthe perception of the National ImmunizationProgram.1% no responseno responseCuba yes 0% no responseDominicanRepublicyesno responseGuatemala yes Random Survey (1164 mothers / guardians)house to house. May 2011Jamaica yes Evaluation of the Immunization Program in 2003;user survey4% measured4% no responseMexico yes National Survey of Health and Nutrition 2006 no responseArmenia yes no responseBelgium yes Vaccination coverage study of infants (18-24months of age) and adolescents in Flanders, 2012.no responseCzechRepublicyes Administrative control 18% measuredGermany yes Representative survey targeting parents ofchildren aged 0-13 years,1% measuredIceland yes Survey among parents no responseItaly yes 1.) Survey on communicative and organizationalaspects of vaccination campaign against HPV andacceptance of the vaccination in the ItalianRegions and proposal for a technical documentfor future campaigns (VALORE): REPORT NOTYET AVAILABLE; 2) Survey on SocialDeterminants of Vaccine Refusal in the VenetoRegion: REPORT AVAILABLE:http://prevenzione.ulss20.verona.it/indagine_scelta_vaccinale.htmlno responseLithuania yes Prevalence study measured35
RussianFederationyesQuestioning during European ImmunizationWeekno responseEritrea yes In December 2011 EPI program review werecarried out at national , subnational &districtlevel &caregivers. By the technical support fromAFRO/ISTno responseRD Congo yes Enquete national de coverture vaccinale 8% measuredUganda yes Social survey on evidence based communication.2012 SIAs/NIDs: Independent survey reports.2012: SIA: Social mobilization survey toconsultant for 35 districts19% measured36
Page 1: APPENDICES TO THEREPORT OF THE SAGE
Page 4 and 5: vaccine hesitancy in low income cou
Page 6 and 7: INDIVIDUAL andGROUPINFLUENCESInflue
Page 8 and 9: Another model reviewed by the Worki
Page 10 and 11: Appendix for Section 4Appendix A4.1
Page 13 and 14: epresented mostly low and middle in
Page 15 and 16: was more hesitant than the younger
Page 17 and 18: a variable or to a lack of understa
Page 19 and 20: References[1] World Health Organiza
Page 21 and 22: Country FVaccine hesitancy is not a
Page 23 and 24: Figure 1. IMs’ opinions regarding
Page 25 and 26: DefinitionVaccination confidence is
Page 27 and 28: Of all participating countries, 19%
Page 29 and 30: Countries from all 3 regions provid
Page 31 and 32: Table 5: Income level of countries
Page 33 and 34: variety of determinants of vaccine
Page 35: Uruguay no no responseVenezuela no
Page 39 and 40: Question 2:Was this % measured or e
Page 41 and 42: Of those countries which submitted
Page 43 and 44: Indicator 2:Indicator 2 was modifie
Page 45 and 46: Table 4. Top three reasons for vacc
Page 47 and 48: The overall response rate to both i
Page 49 and 50: Czech Republic No 1. The fear of si
Page 51 and 52: Kyrgyzstan Yes В 2013 году в
Page 53 and 54: Table A5.3 .1: Survey questions to
Page 55 and 56: Table A5.3.1: Survey questions to a
Page 57 and 58: Table A5.3.2: Survey questions to a
Page 59 and 60: Appendix A5.4 WHO EUR Tailoring Imm
Page 61 and 62: Objective 2 - Characteristics of ev
Page 63 and 64: Most interventions targeted parents
Page 65 and 66: Table 2. PICO questions proposed by
Page 67 and 68: Dialogue-based interventionsEleven
Page 69 and 70: The impact of information-based tra
Page 71 and 72: Conclusions and implicationsLiterat
Page 73 and 74: Appendix A6A.2 Strategies to addres
Page 75 and 76: change in attitudes).- Most studies
Page 77 and 78: Strategies to address vaccine hesit
Page 79 and 80: Table 1.Summary of published litera
Page 81 and 82: Title/ First author/year of publica
Page 87 and 88:
Title/ First author/year of publica
Page 89 and 90:
Title/ First author/year of publica
Page 91 and 92:
References1. Williams, S.E., What a
Page 93 and 94:
Appendix A6C.1 Vaccine Hesitancy La
Page 95 and 96:
ii. Google (Hong Kong)• Used the
Page 97 and 98:
Categories Key Actors Areas ofWork/
Page 99 and 100:
Page 101 and 102:
Categories Key Actors Areas ofActio
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
This landscape analysis, along with
Page 109 and 110:
References for Vaccine Hesitancy La
Page 111:
67 Robert Wood Johnson Foundation.
show all

2_SAGE_Appendicies_Background_final

Create successful ePaper yourself

Delete template?

Save as template?